{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T19:02:19Z","timestamp":1768590139637,"version":"3.49.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,18]],"date-time":"2023-02-18T00:00:00Z","timestamp":1676678400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,18]],"date-time":"2023-02-18T00:00:00Z","timestamp":1676678400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology","doi-asserted-by":"publisher","award":["BT\/PR20794\/MED\/29\/1057\/ 2016"],"award-info":[{"award-number":["BT\/PR20794\/MED\/29\/1057\/ 2016"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001843","name":"DST | Science and Engineering Research Board","doi-asserted-by":"publisher","award":["EMR\/2017\/000454"],"award-info":[{"award-number":["EMR\/2017\/000454"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Type IA topoisomerases maintain DNA topology by cleaving ssDNA and relaxing negative supercoils. The inhibition of its activity in bacteria prevents the relaxation of negative supercoils, which in turn impedes DNA metabolic processes leading to cell death. Using this hypothesis, two bisbenzimidazoles, PPEF and BPVF are synthesized, selectively inhibiting bacterial TopoIA and TopoIII. PPEF stabilizes the topoisomerase and topoisomerase-ssDNA complex, acts as an interfacial inhibitor. PPEF display high efficacy against ~455 multi-drug resistant gram positive and negative bacteria. To understand molecular mechanism of inhibition of TopoIA and PPEF, accelerated MD simulation is carried out, and results suggested that PPEF binds, stabilizes the closed conformation of TopoIA with \u20136Kcal\/mol binding energy and destabilizes the binding of ssDNA. The TopoIA gate dynamics model can be used as a tool to screen TopoIA inhibitors as therapeutic candidates. PPEF and BPVF cause cellular filamentation and DNA fragmentation leading to bacterial cell death. PPEF and BPVF show potent efficacy against systemic and neutropenic mouse models harboring <jats:italic>E. coli<\/jats:italic>, VRSA, and MRSA infection without cellular toxicity.<\/jats:p>","DOI":"10.1038\/s42003-023-04412-1","type":"journal-article","created":{"date-parts":[[2023,2,18]],"date-time":"2023-02-18T17:03:41Z","timestamp":1676739821000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Unraveling topoisomerase IA gate dynamics in presence of PPEF and its preclinical evaluation against multidrug-resistant pathogens"],"prefix":"10.1038","volume":"6","author":[{"given":"Vikas","family":"Maurya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raja","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6160-4586","authenticated-orcid":false,"given":"Reman Kumar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stuti","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pooja","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Palak","family":"Parashar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajni","family":"Gaind","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8865-7602","authenticated-orcid":false,"given":"Kshatresh Dutta","family":"Dubey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Naresh Patwari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vibha","family":"Tandon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,2,18]]},"reference":[{"key":"4412_CR1","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/S1473-3099(17)30753-3","volume":"18","author":"E Tacconelli","year":"2018","unstructured":"Tacconelli, E. et al. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect. Dis. 18, 318\u2013327 (2018).","journal-title":"Lancet Infect. Dis."},{"key":"4412_CR2","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1126\/science.aay3041","volume":"367","author":"J Liu","year":"2020","unstructured":"Liu, J., Gefen, O., Ronin, I., Bar-Meir, M. & Balaban, N. Q. Effect of tolerance on the evolution of antibiotic resistance under drug combinations. Science 367, 200\u2013204 (2020).","journal-title":"Science"},{"key":"4412_CR3","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/s41429-020-0291-8","volume":"73","author":"MS Butler","year":"2020","unstructured":"Butler, M. S. & Paterson, D. L. Antibiotics in the clinical pipeline in October 2019. J. Antibiot. 73, 329\u2013364 (2020).","journal-title":"J. Antibiot."},{"key":"4412_CR4","doi-asserted-by":"publisher","first-page":"2882","DOI":"10.1093\/jac\/dks322","volume":"67","author":"S Bansal","year":"2012","unstructured":"Bansal, S. et al. 3,4-dimethoxyphenyl bis-benzimidazole, a novel DNA topoisomerase inhibitor that preferentially targets Escherichia coli topoisomerase I. J. Antimicrob. Chemother. 67, 2882\u20132891 (2012).","journal-title":"J. Antimicrob. Chemother."},{"key":"4412_CR5","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1016\/j.bbagen.2019.05.015","volume":"1863","author":"R Singh","year":"2019","unstructured":"Singh, R., Pandey, S., Sur, S. & Tandon, V. PPEF: a bisbenzimdazole potent antimicrobial agent interacts at acidic triad of catalytic domain of E. coli topoisomerase IA. Biochim. Biophys. Acta Gen. Subj. 1863, 1524\u20131535 (2019).","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"4412_CR6","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1021\/acs.biochem.8b01102","volume":"58","author":"S Bansal","year":"2019","unstructured":"Bansal, S., Sur, S. & Tandon, V. Benzimidazoles: selective inhibitors of topoisomerase I with differential modes of action. Biochemistry 58, 809\u2013817 (2019).","journal-title":"Biochemistry"},{"key":"4412_CR7","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1146\/annurev.bi.65.070196.003223","volume":"65","author":"JC Wang","year":"1996","unstructured":"Wang, J. C. DNA topoisomerases. Annu Rev. Biochem. 65, 635\u2013692 (1996).","journal-title":"Annu Rev. Biochem."},{"key":"4412_CR8","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/nrm3228","volume":"12","author":"SM Vos","year":"2011","unstructured":"Vos, S. M., Tretter, E. M., Schmidt, B. H. & Berger, J. M. All tangled up: how cells direct, manage and exploit topoisomerase function. Nat. Rev. Mol. Cell Biol. 12, 827\u2013841 (2011).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"4412_CR9","doi-asserted-by":"publisher","first-page":"10432","DOI":"10.1093\/nar\/gks780","volume":"40","author":"K Terekhova","year":"2012","unstructured":"Terekhova, K., Gunn, K. H., Marko, J. F. & Mondrag\u00f3n, A. Bacterial topoisomerase I and topoisomerase III relax supercoiled DNA via distinct pathways. Nucleic Acids Res. 40, 10432\u201310440 (2012).","journal-title":"Nucleic Acids Res."},{"key":"4412_CR10","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1002\/cmdc.201900721","volume":"15","author":"PB Tiwari","year":"2020","unstructured":"Tiwari, P. B. et al. Covalent complex of DNA and bacterial topoisomerase: implications in antibacterial drug development. ChemMedChem 15, 623\u2013631 (2020).","journal-title":"ChemMedChem"},{"key":"4412_CR11","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.ejmech.2016.09.053","volume":"125","author":"X Yu","year":"2017","unstructured":"Yu, X. et al. Synthesis, evaluation, and CoMFA study of fluoroquinophenoxazine derivatives as bacterial topoisomerase IA inhibitors. Eur. J. Med. Chem. 125, 515\u2013527 (2017).","journal-title":"Eur. J. Med. Chem."},{"key":"4412_CR12","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1128\/AAC.04516-14","volume":"59","author":"AA Godbole","year":"2015","unstructured":"Godbole, A. A. et al. Targeting mycobacterium tuberculosis topoisomerase I by small-molecule inhibitors. Antimicrob. Agents Chemother. 59, 1549\u20131557 (2015).","journal-title":"Antimicrob. Agents Chemother."},{"key":"4412_CR13","doi-asserted-by":"publisher","first-page":"4028","DOI":"10.1128\/AAC.00288-16","volume":"60","author":"S Sandhaus","year":"2016","unstructured":"Sandhaus, S. et al. Small-molecule inhibitors targeting topoisomerase I as novel antituberculosis agents. Antimicrob. Agents Chemother. 60, 4028\u20134036 (2016).","journal-title":"Antimicrob. Agents Chemother."},{"key":"4412_CR14","doi-asserted-by":"publisher","first-page":"e01696","DOI":"10.1128\/AAC.01696-17","volume":"62","author":"R Gupta","year":"2018","unstructured":"Gupta, R. et al. Evidence for inhibition of topoisomerase 1A by gold(III) macrocycles and chelates targeting Mycobacterium tuberculosis and Mycobacterium abscessus. Antimicrob. Agents Chemother. 62, e01696\u201317 (2018).","journal-title":"Antimicrob. Agents Chemother."},{"key":"4412_CR15","doi-asserted-by":"publisher","first-page":"6402","DOI":"10.1074\/jbc.M110.148148","volume":"286","author":"MT Garc\u00eda","year":"2011","unstructured":"Garc\u00eda, M. T. et al. New alkaloid antibiotics that target the DNA topoisomerase I of Streptococcus pneumoniae. J. Biol. Chem. 286, 6402\u20136413 (2011).","journal-title":"J. Biol. Chem."},{"key":"4412_CR16","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1038\/s41594-018-0158-x","volume":"25","author":"M Mills","year":"2018","unstructured":"Mills, M., Tse-Dinh, Y. C. & Neuman, K. C. Direct observation of topoisomerase IA gate dynamics. Nat. Struct. Mol. Biol. 25, 1111\u20131118 (2018).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"4412_CR17","doi-asserted-by":"publisher","first-page":"134110","DOI":"10.1063\/5.0018516","volume":"153","author":"S P\u00e1ll","year":"2020","unstructured":"P\u00e1ll, S. et al. Heterogeneous parallelization and acceleration of molecular dynamics simulations in GROMACS. J. Chem. Phys. 153, 134110 (2020).","journal-title":"J. Chem. Phys."},{"key":"4412_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-21141-2","volume":"8","author":"C Kong","year":"2018","unstructured":"Kong, C. et al. Suppression of Staphylococcus aureus biofilm formation and virulence by a benzimidazole derivative, UM-C162. Sci. Rep. 8, 2758 (2018).","journal-title":"Sci. Rep."},{"key":"4412_CR19","unstructured":"Weinstein, M. P. et al. M100 Performance Standards for Antimicrobial Susceptibility Testing (Clinical and Laboratory Standards Institute, 2020)."},{"key":"4412_CR20","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1902\/jop.1992.63.7.576","volume":"63","author":"S Nachnani","year":"1992","unstructured":"Nachnani, S., Scuteri, A., Newman, M. G., Avanessian, A. B. & Lomeli, S. L. E-test: a new technique for antimicrobial susceptibility testing for periodontal microorganisms. J. Periodontol. 63, 576\u2013583 (1992).","journal-title":"J. Periodontol."},{"key":"4412_CR21","doi-asserted-by":"publisher","first-page":"5516","DOI":"10.1093\/nar\/gkn539","volume":"36","author":"XS Pan","year":"2008","unstructured":"Pan, X. S., Dias, M., Palumbo, M. & Fisher, L. M. Clerocidin selectively modifies the gyrase-DNA gate to induce irreversible and reversible DNA damage. Nucleic Acids Res. 36, 5516\u20135529 (2008).","journal-title":"Nucleic Acids Res."},{"key":"4412_CR22","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.molcel.2012.04.027","volume":"46","author":"DJ Dwyer","year":"2012","unstructured":"Dwyer, D. J., Camacho, D. M., Kohanski, M. A., Callura, J. M. & Collins, J. J. Antibiotic-induced bacterial cell death exhibits physiological and biochemical hallmarks of apoptosis. Mol. Cell. 46, 561\u2013572 (2012).","journal-title":"Mol. Cell."},{"key":"4412_CR23","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1093\/nar\/gkq822","volume":"39","author":"AC Gentry","year":"2010","unstructured":"Gentry, A. C., Juul, S., Veigaard, C., Knudsen, B. R. & Osheroff, N. The geometry of DNA supercoils modulates the DNA cleavage activiety of human topoisomerase I. Nucleic Acids Res. 39, 1014\u20131022 (2010).","journal-title":"Nucleic Acids Res."},{"key":"4412_CR24","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1093\/jac\/dkq169","volume":"65","author":"NG Coldham","year":"2010","unstructured":"Coldham, N. G., Webber, M., Woodward, M. J. & Piddock, L. J. V. A 96-well plate fluorescence assay for assessment of cellular permeability and active efflux in Salmonella enterica serovar Typhimurium and Escherichia coli. J. Antimicrob. Chemother. 65, 1655\u20131663 (2010).","journal-title":"J. Antimicrob. Chemother."},{"key":"4412_CR25","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/mmi.12452","volume":"91","author":"S Mahalakshmi","year":"2014","unstructured":"Mahalakshmi, S., Sunayana, M. R., Saisree, L. & Reddy, M. YciM is an essential gene required for regulation of lipopolysaccharide synthesis in Escherichia coli. Mol. Microbiol. 91, 145\u2013157 (2014).","journal-title":"Mol. Microbiol."},{"key":"4412_CR26","doi-asserted-by":"publisher","first-page":"5238","DOI":"10.1021\/jm5003028","volume":"57","author":"H Nimesh","year":"2014","unstructured":"Nimesh, H. et al. Synthesis and biological evaluation of novel bisbenzimidazoles as Escherichia coli topoisomerase IA inhibitors and potential antibacterial agents. J. Med. Chem. 57, 5238\u20135257 (2014).","journal-title":"J. Med. Chem."},{"key":"4412_CR27","doi-asserted-by":"publisher","first-page":"e1004543","DOI":"10.1371\/journal.pgen.1004543","volume":"10","author":"V Usongo","year":"2014","unstructured":"Usongo, V. & Drolet, M. Roles of type 1A topoisomerases in genome maintenance in Escherichia coli. PLoS Genet. 10, e1004543 (2014).","journal-title":"PLoS Genet."},{"key":"4412_CR28","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1471-2180-12-26","volume":"12","author":"A Stockum","year":"2012","unstructured":"Stockum, A., Lloyd, R. G. & Rudolph, C. J. On the viability of Escherichia coli cells lacking DNA topoisomerase I. BMC Microbiol. 12, 26 (2012).","journal-title":"BMC Microbiol."},{"key":"4412_CR29","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1074\/jbc.M411924200","volume":"280","author":"VA Stupina","year":"2005","unstructured":"Stupina, V. A. & Wang, J. C. Viability of Escherichia coli topA mutants lacking DNA topoisomerase I. J. Biol. Chem. 280, 355\u2013360 (2005).","journal-title":"J. Biol. Chem."},{"key":"4412_CR30","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1111\/j.1365-2958.2005.04812.x","volume":"58","author":"CR Lopez","year":"2005","unstructured":"Lopez, C. R. et al. A role for topoisomerase III in a recombination pathway alternative to RuvABC. Mol. Microbiol. 58, 80\u2013101 (2005).","journal-title":"Mol. Microbiol."},{"key":"4412_CR31","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1016\/S0969-2126(00)80027-1","volume":"7","author":"A Mondrag\u00f3n","year":"1999","unstructured":"Mondrag\u00f3n, A. & DiGate, R. The structure of Escherichia coli DNA topoisomerase III. Structure 7, 1373\u20131383 (1999).","journal-title":"Structure"},{"key":"4412_CR32","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1021\/cb500154m","volume":"9","author":"M Rajendram","year":"2014","unstructured":"Rajendram, M. et al. Gyramides prevent bacterial growth by inhibiting DNA gyrase and altering chromosome topology. ACS Chem. Biol. 9, 1312\u20131319 (2014).","journal-title":"ACS Chem. Biol."},{"key":"4412_CR33","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1128\/CMR.00043-12","volume":"25","author":"L Fern\u00e1ndez","year":"2012","unstructured":"Fern\u00e1ndez, L. & Hancock, R. E. W. Adaptive and mutational resistance: role of porins and efflux pumps in drug resistance. Clin. Microbiol. Rev. 25, 661\u2013681 (2012).","journal-title":"Clin. Microbiol. Rev."},{"key":"4412_CR34","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.2165\/11317030-000000000-00000","volume":"69","author":"X-Z Li","year":"2009","unstructured":"Li, X.-Z. & Nikaido, H. Efflux-mediated drug resistance in bacteria: an update. Drugs 69, 1555\u20131623 (2009).","journal-title":"Drugs"},{"key":"4412_CR35","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/nrmicro1464","volume":"4","author":"LJV Piddock","year":"2006","unstructured":"Piddock, L. J. V. Multidrug-resistance efflux pumps - not just for resistance. Nat. Rev. Microbiol. 4, 629\u2013636 (2006).","journal-title":"Nat. Rev. Microbiol."},{"key":"4412_CR36","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/j.bbapap.2008.11.005","volume":"1794","author":"AH Delcour","year":"2009","unstructured":"Delcour, A. H. Outer membrane permeability and antibiotic resistance. Biochim. Biophys. Acta 1794, 808\u2013816 (2009).","journal-title":"Biochim. Biophys. Acta"},{"key":"4412_CR37","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1128\/AAC.37.2.354","volume":"37","author":"M Vaara","year":"1993","unstructured":"Vaara, M. Outer membrane permeability barrier to azithromycin, clarithromycin, and roxithromycin in gram-negative enteric bacteria. Antimicrob. Agents Chemother. 37, 354\u2013356 (1993).","journal-title":"Antimicrob. Agents Chemother."},{"key":"4412_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/srep44419","volume":"7","author":"D Sinha","year":"2017","unstructured":"Sinha, D. et al. Synergistic efficacy of bisbenzimidazole and carbonyl cyanide 3-chlorophenylhydrazone combination against MDR bacterial strains. Sci. Rep. 7, 44419 (2017).","journal-title":"Sci. Rep."},{"key":"4412_CR39","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s002800050801","volume":"42","author":"S Guichard","year":"1998","unstructured":"Guichard, S. et al. Comparison of the pharmacokinetics and efficacy of irinotecan after administration by the intravenous versus intraperitoneal route in mice. Cancer Chemother. Pharmacol. 42, 165\u2013170 (1998).","journal-title":"Cancer Chemother. Pharmacol."},{"key":"4412_CR40","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.cpc.2013.09.018","volume":"185","author":"GA Tribello","year":"2014","unstructured":"Tribello, G. A., Bonomi, M., Branduardi, D., Camilloni, C. & Bussi, G. PLUMED 2: new feathers for an old bird. Comput. Phys. Commun. 185, 604\u2013613 (2014).","journal-title":"Comput. Phys. Commun."},{"key":"4412_CR41","unstructured":"Eswar, N. et al. Comparative protein structure modeling using Modeller. Curr. Protoc. Bioinforma. Chapter 5, Unit-5.6 (2006)."},{"key":"4412_CR42","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1021\/ja026939x","volume":"125","author":"C Dominguez","year":"2003","unstructured":"Dominguez, C., Boelens, R. & Bonvin, A. M. J. J. HADDOCK: A protein-protein docking approach based on biochemical or biophysical information. J. Am. Chem. Soc. 125, 1731\u20131737 (2003).","journal-title":"J. Am. Chem. Soc."},{"key":"4412_CR43","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1063\/1.445869","volume":"79","author":"WL Jorgensen","year":"1983","unstructured":"Jorgensen, W. L., Chandrasekhar, J., Madura, J. D., Impey, R. W. & Klein, M. L. Comparison of simple potential functions for simulating liquid water. J. Chem. Phys. 79, 926\u2013935 (1983).","journal-title":"J. Chem. Phys."},{"key":"4412_CR44","unstructured":"Press, W. H., Teukolsky, S. A, Vetterling, W. T. & Flannery, B. P. Numerical Recipes: The Art of Scientific Computing 3rd edn (Cambridge Univ. Press, 2007)."},{"key":"4412_CR45","doi-asserted-by":"publisher","first-page":"3684","DOI":"10.1063\/1.448118","volume":"81","author":"HJC Berendsen","year":"1984","unstructured":"Berendsen, H. J. C., Postma, J. P. M., Van Gunsteren, W. F., Dinola, A. & Haak, J. R. Molecular dynamics with coupling to an external bath. J. Chem. Phys. 81, 3684\u20133690 (1984).","journal-title":"J. Chem. Phys."},{"key":"4412_CR46","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1080\/00268978400101201","volume":"52","author":"S Nos\u00e9","year":"1984","unstructured":"Nos\u00e9, S. A molecular dynamics method for simulations in the canonical ensemble. Mol. Phys. 52, 255\u2013268 (1984).","journal-title":"Mol. Phys."},{"key":"4412_CR47","doi-asserted-by":"publisher","first-page":"7182","DOI":"10.1063\/1.328693","volume":"52","author":"M Parrinello","year":"1981","unstructured":"Parrinello, M. & Rahman, A. Polymorphic transitions in single crystals: a new molecular dynamics method. J. Appl. Phys. 52, 7182\u20137190 (1981).","journal-title":"J. Appl. Phys."},{"key":"4412_CR48","doi-asserted-by":"publisher","first-page":"10089","DOI":"10.1063\/1.464397","volume":"98","author":"T Darden","year":"1993","unstructured":"Darden, T., York, D. & Pedersen, L. Particle mesh Ewald: an N\u00b7log(N) method for Ewald sums in large systems. J. Chem. Phys. 98, 10089\u201310092 (1993).","journal-title":"J. Chem. Phys."},{"key":"4412_CR49","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1002\/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H","volume":"18","author":"B Hess","year":"1997","unstructured":"Hess, B., Bekker, H., Berendsen, H. J. C. & Fraaije, J. G. E. M. LINCS: a linear constraint solver for molecular simulations. J. Comput. Chem. 18, 1463\u20131472 (1997).","journal-title":"J. Comput. Chem."},{"key":"4412_CR50","doi-asserted-by":"publisher","first-page":"4114","DOI":"10.1021\/acs.jctc.6b00186","volume":"12","author":"R Galindo-Murillo","year":"2016","unstructured":"Galindo-Murillo, R. et al. Assessing the current state of amber force field modifications for DNA. J. Chem. Theory Comput. 12, 4114\u20134127 (2016).","journal-title":"J. Chem. Theory Comput."},{"key":"4412_CR51","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1002\/prot.21123","volume":"65","author":"V Hornak","year":"2006","unstructured":"Hornak, V. et al. Comparison of multiple amber force fields and development of improved protein backbone parameters. Proteins 65, 712\u2013725 (2006).","journal-title":"Proteins"},{"key":"4412_CR52","doi-asserted-by":"publisher","first-page":"3696","DOI":"10.1021\/acs.jctc.5b00255","volume":"11","author":"JA Maier","year":"2015","unstructured":"Maier, J. A. et al. Improving the accuracy of protein side chain and backbone parameters from ff99SB. J. Chem. Theory Comput. 11, 3696\u20133713 (2015).","journal-title":"J. Chem. Theory Comput."},{"key":"4412_CR53","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1002\/jcc.20035","volume":"25","author":"J Wang","year":"2004","unstructured":"Wang, J., Wolf, R. M., Caldwell, J. W., Kollman, P. A. & Case, D. A. Development and testing of a general amber force field. J. Comput Chem. 25, 1157\u20131174 (2004).","journal-title":"J. Comput Chem."},{"key":"4412_CR54","doi-asserted-by":"publisher","first-page":"6676","DOI":"10.1021\/jp045571i","volume":"B109","author":"B Ensing","year":"2005","unstructured":"Ensing, B., Laio, A., Parrinello, M. & Klein, M. L. A recipe for the computation of the free energy barrier and the lowest free energy path of concerted reactions. J. Phys. Chem. B109, 6676\u20136687 (2005).","journal-title":"J. Phys. Chem."},{"key":"4412_CR55","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1471-2091-10-18","volume":"10","author":"T Annamalai","year":"2009","unstructured":"Annamalai, T., Dani, N., Cheng, B. & Tse-Dinh, Y. C. Analysis of DNA relaxation and cleavage activities of recombinant Mycobacterium tuberculosis DNA topoisomerase i from a new expression and purification protocol. BMC Biochem. 10, 10\u201318 (2009).","journal-title":"BMC Biochem."},{"key":"4412_CR56","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/978-1-60761-340-4_4","volume":"582","author":"OJ Bandele","year":"2009","unstructured":"Bandele, O. J. & Osheroff, N. Cleavage of plasmid DNA by eukaryotic topoisomerase II. Methods Mol. Biol. 582, 39\u201347 (2009).","journal-title":"Methods Mol. Biol."},{"key":"4412_CR57","doi-asserted-by":"publisher","first-page":"5318","DOI":"10.1074\/jbc.275.8.5318","volume":"275","author":"CX Zhu","year":"2000","unstructured":"Zhu, C. X. & Tse-Dinh, Y. C. The acidic triad conserved in type IA DNA topoisomerases is required for binding of Mg(II) and subsequent conformational change. J. Biol. Chem. 275, 5318\u20135322 (2000).","journal-title":"J. Biol. Chem."},{"key":"4412_CR58","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/0162-0134(91)80035-G","volume":"42","author":"PL Domanico","year":"1991","unstructured":"Domanico, P. L. & Tse-Dinh, Y. C. Mechanistic studies on E. coli DNA topoisomerase I: divalent ion effects. J. Inorg. Biochem. 42, 87\u201396 (1991).","journal-title":"J. Inorg. Biochem."},{"key":"4412_CR59","doi-asserted-by":"publisher","first-page":"e3000337","DOI":"10.1371\/journal.pbio.3000337","volume":"17","author":"I Nicolas","year":"2019","unstructured":"Nicolas, I., Bordeau, V., Bondon, A., Baudy-Floc\u2019h, M. & Felden, B. Novel antibiotics effective against gram-positive and -negative multi-resistant bacteria with limited resistance. PLoS Biol. 17, e3000337 (2019).","journal-title":"PLoS Biol."},{"key":"4412_CR60","unstructured":"CLSI. M26-A Methods for Determining Bactericidal Activity of Antimicrobial Agents; Approved Guideline (Clinical and Laboratory Standards Institute, 1999)."},{"key":"4412_CR61","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/nature14098","volume":"517","author":"S Epstein","year":"2015","unstructured":"Epstein, S. et al. A new antibiotic kills pathogens without detectable resistance. Nature 517, 455\u2013459 (2015).","journal-title":"Nature"},{"key":"4412_CR62","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1038\/s41559-017-0242-3","volume":"1","author":"MJ Bottery","year":"2017","unstructured":"Bottery, M. J., Wood, A. J. & Brockhurst, M. A. Adaptive modulation of antibiotic resistance through intragenomic coevolution. Nat. Ecol. Evol. 1, 1364\u20131369 (2017).","journal-title":"Nat. Ecol. Evol."},{"key":"4412_CR63","doi-asserted-by":"publisher","first-page":"3003","DOI":"10.1128\/AAC.01584-08","volume":"53","author":"D Andes","year":"2009","unstructured":"Andes, D., Craig, W., Nielsen, L. A. & Kristensen, H. H. In vivo pharmacodynamics characterization of a novel plectasin antibiotic, NZ2114, in a murine infection model. Antimicrob. Agents Chemother. 53, 3003\u20133009 (2009).","journal-title":"Antimicrob. Agents Chemother."},{"key":"4412_CR64","unstructured":"Test No. 425: Acute Oral Toxicity: Up-and-Down Procedure, OECD Guidelines for the Testing of Chemicals, Section 4, (OECD Publishing, Paris, 2022)."},{"key":"4412_CR65","doi-asserted-by":"crossref","unstructured":"Kumar, P., Nagarajan, A., & Uchil, P. D. Analysis of Cell Viability by the MTT Assay. Cold Spring Harb. Protoc. 6 (2018)","DOI":"10.1101\/pdb.prot095505"},{"key":"4412_CR66","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1128\/AAC.40.6.1508","volume":"40","author":"CW Ford","year":"1996","unstructured":"Ford, C. W. et al. In vivo activities of U-100592 and U-100766, novel oxazolidinone antimicrobial agents, against experimental bacterial infections. Antimicrob. Agents Chemother. 40, 1508\u20131513 (1996).","journal-title":"Antimicrob. Agents Chemother."},{"key":"4412_CR67","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-6-55","volume":"6","author":"AF Zuluaga","year":"2006","unstructured":"Zuluaga, A. F. et al. Neutropenia induced in outbred mice by a simplified low-dose cyclophosphamide regimen: characterization and applicability to diverse experimental models of infectious diseases. BMC Infect. Dis. 6, 55 (2006).","journal-title":"BMC Infect. Dis."}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-023-04412-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-023-04412-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-023-04412-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,18]],"date-time":"2023-02-18T17:11:12Z","timestamp":1676740272000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-023-04412-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,18]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["4412"],"URL":"https:\/\/doi.org\/10.1038\/s42003-023-04412-1","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,18]]},"assertion":[{"value":"12 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"195"}}